Nectar Social | $10,600,000 | (Jun 6, 2025)
Voltrac | $2,286,772 | (Jun 6, 2025)
Signify Bio | $15,000,000 | (Jun 6, 2025)
Certified by Founder
Lodge
Ochre Bio
start up
United Kingdom
- Oxford
- 11/10/2022
- Series A
- $30,000,000
Ochre Bio develops RNA therapies for chronic liver diseases, a leading cause of death globally.
Privately held, Ochre Bio is situated within the heart of Oxford’s biotech innovation hub. To learn more, please visit www.ochre-bio.com.
- Industry Biotechnology Research
- Website https://www.ochre-bio.com/
- LinkedIn https://www.linkedin.com/company/ochre-bio/
Related People
Jack O'MearaCo Founder
United Kingdom -
Oxford, England,
I help to get new medicines and healthcare technologies to patients.
Interested in the intersection of science, medicine, and business.
Allay Therapeutics | $57,500,000 | (Jun 6, 2025)
Flank | $10,000,000 | (Jun 6, 2025)
Obvio | $22,000,000 | (Jun 5, 2025)
Manex AI | $9,142,230 | (Jun 5, 2025)
Filament Syfter | $4,800,000 | (Jun 5, 2025)
Vivrelle | $62,000,000 | (Jun 5, 2025)
Sema4.ai | $25,000,000 | (Jun 5, 2025)
Aive | $13,700,350 | (Jun 5, 2025)
Delpha | $2,000,000 | (Jun 5, 2025)